Effect of rapid influenza testing on the clinical management of paediatric influenza

Influenza and other Respiratory Viruses

Volumn 3, Issue 3, 2009, Pages 91-98

  Jennings, Lance C ^a,b   Skopnik, Heino ^c   Burckhardt, Isabel ^d   Hribar, Irene ^e   Del Piero, Luc ^f   Deichmann, Klaus A ^a  

^a CANTERBURY HEALTH LABORATORIES   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c Klinikum Worms   (Germany)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

^e ROCHE INNOVATION CENTER MUNICH   (Germany)

^f University of Freiburg ^*

Author keywords

Antibiotic; Antiviral; Diagnosis; Influenza; Rapid test

Indexed keywords

AMANTADINE; OSELTAMIVIR;

ANTIVIRAL THERAPY; ARTICLE; CHILD; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; COUGHING; DIAGNOSTIC VALUE; FATIGUE; FEMALE; FEVER; HEADACHE; HUMAN; INFANT; INFLUENZA; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RAPID INFLUENZA TEST; RHINORRHEA; SCREENING TEST;

ANTIVIRAL AGENTS; CASE MANAGEMENT; CHILD; CHILD, PRESCHOOL; CLINICAL LABORATORY TECHNIQUES; FEMALE; GERMANY; HEALTH SERVICES RESEARCH; HUMANS; INFANT; INFLUENZA, HUMAN; MALE; MOLECULAR DIAGNOSTIC TECHNIQUES; QUESTIONNAIRES;

EID: 65249190171     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/j.1750-2659.2009.00079.x     Document Type: Article

References (40)

1. Heikkinen T. Influenza in children. Acta Paediatr 2006; 95: 778-784.
2. Monto AS, Sullivan KM. Acute respiratory illness in the community. Frequency of illness and the agents involved. Epidemiol Infect 1993; 110: 145-160.
3. Hurwitz ES, Haber M, Chang A et al. Studies of the 1996-1997 inactivated influenza vaccine among children attending day care: Immunologic response, protection against infection, and clinical effectiveness. J Infect Dis 2000; 182: 1218-1221.
4. Heikkinen T, Silvennoinen H, Peltola V et al. Burden of influenza in children in the community. J Infect Dis 2004; 190: 1369-1373.
5. Peltola V, Ziegler T, Ruuskanen O. Influenza A and B virus infections in children. Clin Infect Dis 2003; 36: 299-305.
6. Tsolia MN, Logotheti I, Papadopoulos NG et.al. Impact of influenza infection in healthy children examined as outpatients and their families. Vaccine 2006; 24: 5970-5976.
7. Lahti E, Peltola V, Virkki R, Ruuskanen O. Influenza pneumonia. Pediatr Infect Dis J 2006; 25: 160-164.
8. Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000; 342: 225-231.
9. Izurieta HS, Thompson WW, Kramarz P et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000; 342: 232-239.
10. Simonsen L, Fukuda K, Schonberger LB, Cox NJ. The impact of influenza epidemics on hospitalizations. J Infect Dis 2000; 181: 831-837.
11. Smith NM, Bresee JS, Shay DK et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55: 1-42.
12. Poehling KA, Edwards KM, Weinberg GA et al. The underrecognized burden of influenza in young children. N Engl J Med 2006; 355: 31-40.
13. Monto AS, Davenport FM, Napier JA, Francis T Jr. Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. J Infect Dis 1970; 122: 16-25.
14. Glezen WP, Couch RB. Interpandemic influenza in the Houston area, 1974-76. N Engl J Med 1978; 298: 587-592.
15. Ramet J, Weil-Olivier C, Sedlak W. Influenza vaccination: The paediatric perspective. Vaccine 2007; 25: 780-787.
16. Fiore AE, Shay DK, Haber P et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 2007; 56: 1-54.
17. Nicholson KG, Aoki FY, Osterhaus AD et al. Efficacy and safety of oseltamivir in treatment of acute influenza: A randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet 2000; 355: 1845-1850.
18. Whitley RJ, Hayden FG, Reisinger KS et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J 2001; 20: 127-133.
19. Kaiser L, Wat C, Mills T et al. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med 2003; 163: 1667-1672.
20. Hayden FG, Osterhaus AD, Treanor JJ et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. N Engl J Med 1997; 337: 874-880.
21. Hedrick JA, Barzilai A, Behre U et al. Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: A randomized controlled trial. Pediatr Infect Dis J 2000; 19: 410-417.
22. The MIST Study Group. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group. Lancet 1998; 352: 1877-1881.
23. Roche Products Limited. Tamiflu ® Summary of Product Characteristics, 2007. Available at: http://emc.medicines.org.uk/ default.aspx
24. GlaxoSmithKline UK. Relenza ® Summary of Product Characteristics, 2008. Available at: http://emc.medicines.org.uk/default.aspx (Accessed 3 March 2009).
25. Fleming DM, Pannell RS, Elliot AJ, Cross KW. Respiratory illness associated with influenza and respiratory syncytial virus infection. Arch Dis Child 2005; 90: 741-746.
26. Charles PG, Grayson ML. Point-of-care tests for lower respiratory tract infections. Med J Aust 2007; 187: 36-39.
27. World Health Organization (WHO). WHO recommendations on the use of rapid testing for influenza diagnosis, 2005. Available at: http://www.who.int/ csr/disease/avian_influenza/guidelines/rapid_testing/en/ (Accessed 3 March 2009).
28. Low D. Reducing antibiotic use in influenza: Challenges and rewards. Clin Microbiol Infect 2008; 14: 298-306.
29. Poehling KA, Zhu Y, Tang YW, Edwards K. Accuracy and impact of a point-of-care rapid influenza test in young children with respiratory illnesses. Arch Pediatr Adolesc Med 2006; 160: 713-718.
30. Sharma V, Dowd MD, Slaughter AJ, Simon SD. Effect of rapid diagnosis of influenza virus type a on the emergency department management of febrile infants and toddlers. Arch Pediatr Adolesc Med 2002; 156: 41-43.
31. Esposito S, Marchisio P, Morelli P, Crovari P, Principi N. Effect of a rapid influenza diagnosis. Arch Dis Child 2003; 88: 525-526.
32. Bonner AB, Monroe KW, Talley LI, Klasner AE, Kimberlin DW. Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: Results of a randomized, prospective, controlled trial. Pediatrics 2003; 112: 363-367.
33. Peltola V, Reunanen T, Ziegler T, Silvennoinen H, Heikkinen T. Accuracy of clinical diagnosis of influenza in outpatient children. Clin Infect Dis 2005; 41: 1198-1200.
34. Santibanez TA, Santoli JM, Bridges CB, Euler GL. Influenza vaccination coverage of children aged 6 to 23 months: The 2002-2003 and 2003-2004 influenza seasons. Pediatrics 2006; 118: 1167-1175.
35. Centers for Disease Control and Prevention (CDC). Influenza vaccination coverage among children aged 6-59 months - six immunization information system sentinel sites, United States, 2006-07 influenza season. MMWR Morb Mortal Wkly Rep 2007; 56: 963-965.
36. Centers for Disease Control and Prevention (CDC). Assessment of the effectiveness of the 2003-04 influenza vaccine among children and adults - Colorado 2003. Morb Mortal Weekly Rep 2004; 53: 707-710.
37. Barr CE, Schulman K, Iacuzio D, Bradley JS. Effect of oseltamivir on the risk of pneumonia and use of health care services in children with clinically diagnosed influenza. Curr Med Res Opin 2007; 23: 523-531.
38. Aoki FY, Macleod MD, Paggiaro P et al. Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrob Chemother 2003; 51: 123-129.
39. Whitley RJ, Reisinger K, Dutkowski R. Early oseltamivir initiation produces marked reductions in illness duration, symptom severity and secondary complications in children with influenza. Options for the Control of Influenza VI 2007, Toronto, June 17-23 2007, Abstract O98 [Generic].
40. Noyola DE, Demmler GJ. Effect of rapid diagnosis on management of influenza A infections. Pediatr Infect Dis J 2000; 19: 303-307.